Skip to main content
SpringerLink
Log in

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi YL et al. Array-based genomic resequencing of human leukemia. Oncogene 2010; 29: 3723–3731.

    Article  CAS  Google Scholar 

  2. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424–2433.

    Article  CAS  Google Scholar 

  3. Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011; e-pub ahead of print 18 March 2011.

    Google Scholar 

  4. Abdel-Wahab O, Pardanani A, Patel J, Wadleigh M, Lasho T, Heguy A et al. Concomitant analysis of ASXL1 and EZH2 mutations in myelofibrosis, chronic myelomonocytic leukemia, and blast-phase myeloproliferative neoplasms. Leukemia 2011; e-pub ahead of print 01 April 2011.

    Google Scholar 

  5. Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 2010; 115: 1703–1708.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from the Gabrielle's Angel Foundation and from the Starr Cancer Consortium to RLL. RLL is an Early Career Award Recipient of the Howard Hughes Medical Institute and is a Geoffrey Beene Junior Faculty Chair at Memorial Sloan Kettering Cancer Center.

Author information

Authors and Affiliations

  1. Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center, New York, NY, USA

    O Abdel-Wahab, R Rampal & R L Levine

  2. Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    O Abdel-Wahab, R Rampal & R L Levine

  3. Division of Hematology, Mayo Clinic, Rochester, MN, USA

    A Pardanani, T L Lasho & A Tefferi

Authors
  1. O Abdel-Wahab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Pardanani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Rampal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T L Lasho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R L Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O Abdel-Wahab.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdel-Wahab, O., Pardanani, A., Rampal, R. et al. DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia 25, 1219–1220 (2011). https://doi.org/10.1038/leu.2011.82

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.82

  • Springer Nature Limited

This article is cited by

Search

Navigation